These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29451070)

  • 1. Confounders other than comorbidity explain survival differences in Danish and Swedish ovarian cancer patients - a comparative cohort study.
    Noer MC; Leandersson P; Paulsen T; Rosthøj S; Antonsen SL; Borgfeldt C; Høgdall C
    Acta Oncol; 2018 Aug; 57(8):1100-1108. PubMed ID: 29451070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian Cancer and Comorbidity: Is Poor Survival Explained by Choice of Primary Treatment or System Delay?
    Noer MC; Sperling CD; Ottesen B; Antonsen SL; Christensen IJ; Høgdall C
    Int J Gynecol Cancer; 2017 Jul; 27(6):1123-1133. PubMed ID: 28604447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new clinically applicable age-specific comorbidity index for preoperative risk assessment of ovarian cancer patients.
    Noer MC; Sperling CD; Antonsen SL; Ottesen B; Christensen IJ; Høgdall C
    Gynecol Oncol; 2016 Jun; 141(3):471-478. PubMed ID: 27056103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study.
    Tetsche MS; Nørgaard M; Jacobsen J; Wogelius P; Sørensen HT
    Int J Gynecol Cancer; 2008; 18(3):421-7. PubMed ID: 17692093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do stage of disease, comorbidity or access to treatment explain socioeconomic differences in survival after ovarian cancer? - A cohort study among Danish women diagnosed 2005-2010.
    Ibfelt EH; Dalton SO; Høgdall C; Fagö-Olsen CL; Steding-Jessen M; Osler M; Johansen C; Frederiksen K; Kjær SK
    Cancer Epidemiol; 2015 Jun; 39(3):353-9. PubMed ID: 25841586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
    Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
    BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity is an independent prognostic factor for the survival of ovarian cancer: a Danish register-based cohort study from a clinical database.
    Sperling C; Noer MC; Christensen IJ; Nielsen ML; Lidegaard Ø; Høgdall C
    Gynecol Oncol; 2013 Apr; 129(1):97-102. PubMed ID: 23290990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of comorbidity on mortality in ovarian cancer patients.
    Stålberg K; Svensson T; Lönn S; Kieler H
    Gynecol Oncol; 2014 May; 133(2):298-303. PubMed ID: 24582801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer.
    Mellemgaard A; Lüchtenborg M; Iachina M; Jakobsen E; Green A; Krasnik M; Møller H
    J Thorac Oncol; 2015 Feb; 10(2):272-9. PubMed ID: 25371078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients.
    Jørgensen TL; Teiblum S; Paludan M; Poulsen LØ; Jørgensen AY; Bruun KH; Hallas J; Herrstedt J
    Gynecol Oncol; 2012 Nov; 127(2):367-74. PubMed ID: 22800653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.
    El-Galaly TC; Jakobsen LH; Hutchings M; de Nully Brown P; Nilsson-Ehle H; Székely E; Mylam KJ; Hjalmar V; Johnsen HE; Bøgsted M; Jerkeman M
    J Clin Oncol; 2015 Dec; 33(34):3993-8. PubMed ID: 26438115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012.
    Edwards HM; Noer MC; Sperling CD; Nguyen-Nielsen M; Lundvall L; Christensen IJ; Høgdall C
    Acta Oncol; 2016 Jun; 55 Suppl 2():36-43. PubMed ID: 27355258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
    Hannibal CG; Cortes R; Engholm G; Kjaer SK
    Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centralized treatment of advanced stages of ovarian cancer improves survival: a nationwide Danish survey.
    Fagö-Olsen CL; Høgdall C; Kehlet H; Christensen IJ; Ottesen B
    Acta Obstet Gynecol Scand; 2011 Mar; 90(3):273-9. PubMed ID: 21306310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Holmberg L
    Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study.
    Tetsche MS; Nørgaard M; Pedersen L; Lash TL; Sørensen HT
    BMC Cancer; 2006 Jul; 6():189. PubMed ID: 16846496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometriosis as a prognostic factor for cancer survival.
    Melin A; Lundholm C; Malki N; Swahn ML; Sparen P; Bergqvist A
    Int J Cancer; 2011 Aug; 129(4):948-55. PubMed ID: 20949560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does stage of cancer, comorbidity or lifestyle factors explain educational differences in survival after endometrial cancer? A cohort study among Danish women diagnosed 2005-2009.
    Seidelin UH; Ibfelt E; Andersen I; Steding-Jessen M; Høgdall C; Kjær SK; Dalton SO
    Acta Oncol; 2016 Jun; 55(6):680-5. PubMed ID: 27144961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.